Miso Clinic · Clinical Reference

Radiesse: the best-evidenced product in our booster cabinet

Of the six collagen boosters and skin boosters this clinic stocks, Radiesse carries by far the most regulatory approval and clinical data — FDA approved since 2006, licensed in Korea since 2010, with nearly two decades of published work behind it. It is also, like every calcium hydroxylapatite product, impossible to dissolve out. This page sets out what is actually approved and where, and what the treatment will not do.

Clinical reference About a 10-minute read Reviewed 2026 Miso Clinic, Daegu · Dr. Lee Chi-Hak 한국어판

In one paragraph

Radiesse is an injectable collagen stimulator from Merz Aesthetics, consisting of calcium hydroxylapatite (CaHA) microspheres suspended in a carrier gel. CaHA belongs to the same mineral family as bone and tooth. On injection the gel provides immediate volume; once absorbed, the remaining microspheres stimulate new collagen formation. It has been licensed in Korea since 2010 and in use here since 2011.

At a glance

Radiesse
CategoryTissue-repair material, licensed in Korea since 2010
Active materialCaHA microspheres in carrier gel
Microsphere size25–45 μm, 30% of total weight
Korean licensed indicationsTemporary improvement of facial wrinkles; temporary restoration of volume in the dorsum of the hand
ManufacturerMerz Aesthetics (Korean import and distribution by Merz Aesthetics Korea)
ActionImmediate volume (gel) → gel absorbed → collagen formation around microspheres
ReversibleNo — no agent exists that dissolves CaHA
TargetsFirmness, dermal thickness, gentle contour support

How CaHA works — three stages

Calcium hydroxylapatite belongs to the same mineral family as human bone and tooth — a material the body already recognises, formed into microscopic spheres and suspended in gel.

Stage 1 — what the gel does immediately

The carrier gel occupies space at the injection site. The effect resembles a filler, and it is temporary.

Stage 2 — the gel is absorbed

Over some weeks the gel resorbs and part of the initial fullness goes with it. This is the stage patients most often read as failure, when it is in fact the point at which the real mechanism begins.

Stage 3 — what the microspheres do

Cells are recruited around the remaining particles and new collagen is laid down. Histology describes type III collagen rising first and type I increasing later, with elastin increasing alongside. The microspheres biodegrade over one to two years.

To be accurate about the limits: the precise pathway has not been fully established. A foreign-body response to the particles and calcium-ion signalling have both been proposed, and reviews of the field state plainly that supporting evidence remains incomplete.

What is approved, and where

Much of what you will read about Radiesse online reflects United States approvals, which differ from the Korean licence. The distinction matters, so here it is explicitly.

Indications by regulator
SiteUS FDAKorea MFDS
Facial wrinklesApproved (2006)Licensed
Dorsal hand volumeApproved (2015)Licensed (2017)
Jawline contourApproved (2022)Not within the Korean licence
Décolleté wrinklesApproved (2026)Not within the Korean licence

In Korea the licence covers facial wrinkles and dorsal hand volume. This page is written to that scope.

The hand indication is worth dwelling on. Hands show age early and there is relatively little that treats them well. Radiesse holds a formal Korean indication for restoring dorsal hand volume, and that is part of why this clinic stocks it alongside the other five.

A note for patients travelling from abroad — If you have read about jawline or décolleté treatment with Radiesse, those approvals are American. Korean clinics work within the Korean licence. We will tell you exactly what is possible at consultation.

The part about not being able to take it back

That the effect is durable and that it cannot be removed are the same property seen from two sides. Particles remain and keep working, which is why it lasts — and why it cannot be undone.

A hyaluronic acid filler can be dissolved with hyaluronidase. CaHA has no equivalent. Hyaluronidase does not dissolve it, and sodium thiosulfate, once proposed as an alternative, showed no dissolution effect in later work. The measures used when a nodule appears — saline injection with massage, intralesional treatment, laser, ultimately surgical removal — disperse or extract the material; they do not dissolve it.

  • Do not overcorrect. Too little can be added to later; too much cannot be taken back
  • Do not place it superficially. Superficial placement is the commonest reason a nodule becomes visible
  • Avoid the sites where nodules cluster. We do not treat lips or the tear trough with CaHA
  • Do not try to finish in one sitting. Build in stages and review

The microspheres do biodegrade over one to two years, so time resolves most things — but it is better not to spend that time unhappy.

How good is the evidence

Here Radiesse differs from the other boosters: the trials behind the regulatory approvals actually exist and are public.

The 2006 FDA approval rested on a randomised split-face study of 117 patients — comparing the two sides of the same face, against a control filler, in the nasolabial folds. The 2015 hand indication and the 2026 décolleté indication each required their own trials; the décolleté study followed 152 patients to 84 weeks in a multicentre randomised design.

Tissue-level findings have been reproduced too: compared against hyaluronic acid filler, treated sites showed higher type I collagen staining at nine months.

For balance: a 2024 systematic review of thirteen controlled studies (1,171 patients) concluded that they carry risk of bias and vary enough between themselves that pooled analysis was not possible. Reported duration also varies widely — twelve to thirty months across studies. The instructions for use put established safety and effectiveness at three years for the face and one year for the hands.

A fair summary: the best-evidenced product in this category, but not one where anyone can promise you a number of months.

How this differs from DCLASSY

Miso Clinic stocks two CaHA products, Radiesse and DCLASSY. They are the same class, and the real difference is the volume of evidence behind each.

Everything described above belongs to Radiesse. DCLASSY holds a Korean licence as a tissue-repair material, but no clinical trial data specific to it is publicly available, and no published comparison of the two products' microsphere concentration or gel composition exists. So there is no basis for ranking them — only the plain fact that far more data has accumulated on the Radiesse side.

We stock both to have a choice, decided by site, objective, and what the patient values.

DCLASSY reference →  ·  Six boosters compared →

Who it suits, and who it does not

Reasonable candidates

  • Thinning skin combined with a clear loss of firmness
  • Gentle hollowing of the cheeks or temples that casts shadow
  • Loss of volume on the backs of the hands, with tendons and veins standing out — a licensed indication in Korea
  • Patients who want to see some change straight away
  • Patients who prefer the better-evidenced option

Where Radiesse is the wrong choice

  • Lips — safety not established and nodules reported; we do not treat lips with CaHA
  • Tear trough — a site where nodules cluster
  • Pigmentation, redness, pore size, acne scarring — not what CaHA treats
  • Deep dynamic lines — botulinum toxin territory
  • Precise contour sculpting — irreversibility makes fine adjustment unwise; HA filler is the right tool
  • Pregnancy or breastfeeding, under 18, active infection at the site, bleeding disorders, history of severe allergy, autoimmune or granulomatous disease
If you have imaging — CaHA is radiopaque and appears clearly on CT. Tell the clinician performing any facial CT or related imaging that you have had this treatment, so it is not mistaken for a lesion.

What the appointment involves

The consultation begins by separating hollowing from loss of firmness. If Radiesse is appropriate, site, volume and depth follow — and because the material cannot be reversed, we spend longer on this step.

Topical anaesthetic is applied, then the product is placed by cannula or needle into the deep dermis or subdermal plane. Superficial placement is avoided on principle, and volume is distributed rather than deposited in one spot. On the hands the product goes into the plane between tendons and veins by cannula and is then smoothed evenly.

Immediately post-treatment the gel makes the result look slightly fuller than it will finally be; that settles over some weeks. We account for this by deliberately placing less at the outset.

Timeline

  1. Day 0
    Immediate change and swellingGel volume mixed with treatment response. Not the final result, and looking slightly overfull here is expected.
  2. Week 1–2
    Swelling and bruising settleErythema, oedema and bruising mostly resolve in this window.
  3. Month 1–2
    The gel is absorbedSome of the initial fullness recedes. Not loss of effect — the point at which the real mechanism starts, and when patients worry most.
  4. Month 3–6
    Collagen change establishesCollagen formation around the microspheres accumulates and the change in firmness becomes clear. We review here.
  5. Year 1–2
    Gradual breakdownThe microspheres biodegrade and the effect softens with them. Reported duration ranges from about twelve to thirty months, with considerable individual variation.

Downtime and aftercare

Swelling and bruising can last somewhat longer than with other boosters. Allow at least a week before anything important. After hand treatment, avoid heavy use of the hands for a few days.

  • Do not press or rub the treated area yourself — product can be displaced
  • Avoid sauna, jjimjilbang, strenuous exercise and alcohol on the day
  • Use sun protection diligently
  • If something palpable remains, or one side stands proud, come back rather than waiting
Adverse effects — Swelling, erythema, bruising and pain are common and usually settle within one to two weeks. The commonest adverse event with CaHA is nodule formation, associated with superficial placement, excessive volume, and mobile areas. Nodules are reported more often on the hands than on the face, so volume and plane are planned more conservatively there. Most are invisible and resorb, but if one is palpable or visible, return so we can discuss treatment. Rarely, intravascular injection has been reported to cause skin necrosis, visual impairment and blindness. Because no agent dissolves CaHA, prevention is the whole strategy — tell us immediately if you experience sudden severe pain, visual disturbance or skin colour change during or after treatment. Tell your clinician beforehand if you are pregnant or breastfeeding, or have a bleeding disorder, a history of severe allergy, or autoimmune disease.

Common questions

Is it really true that it cannot be dissolved?
Yes. Hyaluronidase, which dissolves HA filler, has no effect on CaHA, and no agent that breaks CaHA down exists. That does not mean nothing can be done if a problem arises: saline injection with massage to disperse the material, intralesional treatment, laser, and surgical extraction as a last resort form a graded set of options. The microspheres also biodegrade over one to two years, so nothing is permanent. But irreversibility is exactly why we place conservatively from the start.
Can it be used on the hands?
Yes — it is a formally licensed indication in Korea. Hands show age early: as volume is lost, tendons and veins stand out, and relatively few treatments address this well. Because the hands are constantly in motion, nodules are reported more often there than on the face, so we plan volume and plane more conservatively and treat in stages.
I read that it's approved for the jawline and décolleté
Those approvals (2022 and 2026) are from the U.S. FDA. The Korean licence covers facial wrinkles and dorsal hand volume. A great deal of what circulates online reflects American indications, which is easy to mistake for local ones. We will tell you exactly what is possible at consultation.
It's been a month and the effect seems to have gone
The most common thing we hear, and usually normal. The initial volume comes from the carrier gel, absorbed over one to two months, taking that fullness with it. The actual mechanism — collagen formation — accumulates afterwards and becomes clear between three and six months. Patients not told about this window reasonably conclude the treatment failed, which is why we explain it beforehand.
How long does it last?
The microspheres biodegrade over one to two years, and reported duration ranges from about twelve to thirty months. The instructions for use put established safety and effectiveness at three years for the face and one year for the hands. Individual variation is wide and site and volume matter, so a single figure would mislead. Within this category it is one of the longer-lasting options.
How likely are nodules?
Nodules account for most of the adverse events reported with CaHA. In facial studies at appropriate depth and volume they were uncommon and mostly invisible and self-resolving. Problems arise chiefly from placement that is too superficial, too much product in one spot, or highly mobile areas — the hands being the clearest example. Where and how much is essentially the whole of this treatment.
Radiesse or DCLASSY?
No published comparison exists, so there is no basis for ranking them. What is true is that considerably more clinical data has accumulated on Radiesse. Both are CaHA and we stock both, choosing by site and objective. If the weight of evidence matters to you, we will factor that in.
What does it cost?
It depends on volume, treatment area and whether other treatments are combined. Korean medical advertising rules govern how treatment fees may be published, so we do not list them here; we will give you exact figures at consultation.

About the authoring clinic

This reference was written and reviewed by Dr. Lee Chi-Hak, director of Miso Clinic in Daegu, South Korea. The clinic stocks six collagen boosters and skin boosters with genuinely different active materials — liquid PCL (GOURI), PN (Rejuran), hADM (Re2O, CellREDM) and CaHA (Radiesse, DCLASSY) — and selects between them according to which kind of ageing the face is actually showing. A clinic holding one product will use that product. See our comparison of all six and the references on liquid PCL, polynucleotide, hADM, CellREDM and DCLASSY.

Miso Clinic
DirectorDr. Lee Chi-Hak
Address4F Bombom Building, 125 Dongdeok-ro, Jung-gu, Daegu, South Korea · Exit 1, Kyungpook National University Hospital Station
Telephone+82 53-428-2700
KakaoTalkMiso Clinic channel
HoursWeekdays 11:00–19:00 (lunch 13:00–14:00) / Saturday 10:00–16:00 (no lunch break) / Closed Sundays and public holidays
Websiteclinicmiso.co.kr
Reference libraryMiso Clinic clinical reference library — all six
한국어래디어스 진료 자료 (Korean)

References

  1. U.S. Food and Drug Administration. Radiesse Injectable Implant — Summary of Safety and Effectiveness Data (P050052 and subsequent supplements). Approved indications and trial results.
  2. Merz Aesthetics Korea. Korean licensed indication and product information.
  3. Mechanisms of Action of Calcium Hydroxylapatite, Aesthetic Surgery Journal (2025). Three-stage action, proposed mechanisms, and the authors' own statement of evidentiary limits.
  4. Calcium Hydroxylapatite in Aesthetic Medicine: A Systematic Review, Journal of Clinical Medicine (2024). Thirteen controlled studies, 1,171 patients, with risk-of-bias assessment.
  5. Safety of Calcium Hydroxylapatite: A Review (2017). Adverse events across 5,081 treatments — nodule frequency and distribution.
  6. Management of Nodules Following Calcium Hydroxylapatite Injection, Aesthetic Surgery Journal (2024). Graded management algorithm.
  7. Miso Clinic protocol — injection depth and site selection, dorsal hand technique, prevention of overcorrection, nodule management pathway.

This page provides general information about an aesthetic treatment and does not substitute for medical diagnosis or care. Outcomes and adverse effects vary with individual skin condition, age and underlying illness, and no result is guaranteed. Decisions about treatment should be made in an in-person consultation with a qualified clinician.

← Miso Clinic home